ALNYALNYLAM PHARMACEUTICALS, INC.
Health Care
Stockholders' Equity Attributable to Parent revised up 148.1% for Q3 2025
This is the 2nd largest revision in ALNY's history.
Stockholders' Equity Attributable to Parent·As of Sep 30, 2025
Major restatement$580.2M▲ 148.1%
was$233.9M
Revised up in a 10-Q.
Verify against SEC filingsShow
As reported$233.9M
Accepted 2025-10-300001628280-25-047345
Restated$580.2M
Accepted 2026-10-290001178670-26-000076
StockholdersEquity · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time ALNY — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.